DFHBI

CAS No. 1241390-29-3

DFHBI ( —— )

Catalog No. M23414 CAS No. 1241390-29-3

DFHBI is a small molecule, resembles the chromophore of green fluorescent protein (GFP).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 34 In Stock
5MG 55 In Stock
10MG 91 In Stock
25MG 194 In Stock
50MG 324 In Stock
100MG 482 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    DFHBI
  • Note
    Research use only, not for human use.
  • Brief Description
    DFHBI is a small molecule, resembles the chromophore of green fluorescent protein (GFP).
  • Description
    DFHBI is a small molecule, resembles the chromophore of green fluorescent protein (GFP). Spinach and DFHBI are essentially nonfluorescent when unbound. The Spinach-DFHBI complex is brightly fluorescent both in vitro and in living cells.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1241390-29-3
  • Formula Weight
    252.2
  • Molecular Formula
    C12H10F2N2O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:83.33 mg/mL (330.39 mM)
  • SMILES
    O=C1N(C)C(C)=N/C1=C\C2=CC(F)=C(O)C(F)=C2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Song W, et al. Plug-and-play fluorophores extend the spectral properties of Spinach. J Am Chem Soc. 2014 Jan 29;136(4):1198-201.
molnova catalog
related products
  • DL-Penicillamine

    The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease.

  • Liriope muscari bail...

    Saponin C from Liriope muscari can be extracted from Liriope muscari, family Liliaceae.

  • Icotinib Hydrochlori...

    Icotinib Hydrochloride is the hydrochloride salt form of icotinib, an orally available quinazoline-based inhibitor of EGFR, with potential antineoplastic activity.